Omeros | OMER - Ebit

Stock Price
11.51
Daily Change
-0.08 -0.69%
Monthly
2.49%
Yearly
53.98%
Q1 Forecast
11.68

Omeros reported $-48.15M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
Adma Biologics USD 49.19M 7.26M Sep/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
Immunic USD -22.81M 756K Jun/2024
Insmed USD -249.71M 11.64M Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
MacroGenics USD 20.16M 55.51M Sep/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 3.19M 9.96M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024